| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Myriad Uranium Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.14 |
| 52 Week High | CA$0.27 |
| 52 Week Low | CA$0.091 |
| Beta | -0.65 |
| 11 Month Change | -29.15% |
| 3 Month Change | -34.72% |
| 1 Year Change | -37.05% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -49.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| C3Q | DE Metals and Mining | DE Market | |
|---|---|---|---|
| 7D | -1.4% | 2.0% | 0.09% |
| 1Y | -37.1% | -28.6% | 3.1% |
Return vs Industry: C3Q underperformed the German Metals and Mining industry which returned -28.6% over the past year.
Return vs Market: C3Q underperformed the German Market which returned 3.1% over the past year.
Price Volatility
| C3Q volatility | |
|---|---|
| C3Q Average Weekly Movement | 15.3% |
| Metals and Mining Industry Average Movement | 5.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: C3Q's share price has been volatile over the past 3 months.
Volatility Over Time: C3Q's weekly volatility has decreased from 22% to 15% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Tom Lamb | myriaduranium.com |
Myriad Uranium Corp. operates as a uranium mineral exploration company in Africa. The company has an option to acquire a 100% interest in 1,822 square kilometers of uranium exploration licenses in the Tim Mersoi Basin, Niger. It also holds a 100% interest in the Millen Mountain property, which comprises various mineral claims covering approximately 1,280 hectares located in the province of Nova Scotia.
Myriad Uranium Corp. Fundamentals Summary
| C3Q fundamental statistics | |
|---|---|
| Market cap | €5.07m |
| Earnings (TTM) | -€1.73m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.9x
P/E RatioIs C3Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| C3Q income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.54m |
| Earnings | -CA$2.54m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.073 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did C3Q perform over the long term?
See historical performance and comparison